Abstract
Chemoinfectomics (chemical infectomics) is the study of small exogenous molecules that are highly specified to define molecular targets (e.g., genes, proteins, glycans, and lipids) or infectomic signatures, to enable functional analysis of microbes and their hosts, and to uncover new antimicrobial drug leads. It requires multidisciplinary expertise in chemical omics (chemogenomics, chemoproteomics, chemoglycomics and chemolipidomics), infectious diseases, and computational sciences (bioinformatics, cheminformatics, large scale statistics and machine learning methods). Chemoinfectomics will overcome the major limitation of the conventional paradigm of managing infectious diseases, which has mainly targeted on microorganisms with low selectivity. The development of drug resistance to both pathogenic and nonpathogenic microbes has been one of the most serious disadvantages of the traditional microbe-directed drug targeting strategies. Therefore, a new chemoinfectomics-based drug discovery paradigm has emerged, focusing on identifying and targeting host factors essential for microbial interactions and pathogenesis. Innovative strategies combining chemoinfectomics, computational biology, and conventional targeting of microbial virulence factors have the potential to greatly augment the protective host factors and to specifically and efficiently eliminate the invading pathogen.
Keywords: Activity-based profiling (ABP), chemogenomics, chemoglycomics, chemoinfectiomics, chemolipidomics, chemoproteomics, infectomes, miroarrays, multidrug resistance (MDR).
Anti-Infective Agents
Title:Chemoinfectomics in Drug Design and Development
Volume: 11 Issue: 2
Author(s): Sheng-He Huang, Hongwei Xia, Feng Chi, Naila K. Khalaf and Ambrose Jong
Affiliation:
Keywords: Activity-based profiling (ABP), chemogenomics, chemoglycomics, chemoinfectiomics, chemolipidomics, chemoproteomics, infectomes, miroarrays, multidrug resistance (MDR).
Abstract: Chemoinfectomics (chemical infectomics) is the study of small exogenous molecules that are highly specified to define molecular targets (e.g., genes, proteins, glycans, and lipids) or infectomic signatures, to enable functional analysis of microbes and their hosts, and to uncover new antimicrobial drug leads. It requires multidisciplinary expertise in chemical omics (chemogenomics, chemoproteomics, chemoglycomics and chemolipidomics), infectious diseases, and computational sciences (bioinformatics, cheminformatics, large scale statistics and machine learning methods). Chemoinfectomics will overcome the major limitation of the conventional paradigm of managing infectious diseases, which has mainly targeted on microorganisms with low selectivity. The development of drug resistance to both pathogenic and nonpathogenic microbes has been one of the most serious disadvantages of the traditional microbe-directed drug targeting strategies. Therefore, a new chemoinfectomics-based drug discovery paradigm has emerged, focusing on identifying and targeting host factors essential for microbial interactions and pathogenesis. Innovative strategies combining chemoinfectomics, computational biology, and conventional targeting of microbial virulence factors have the potential to greatly augment the protective host factors and to specifically and efficiently eliminate the invading pathogen.
Export Options
About this article
Cite this article as:
Huang Sheng-He, Xia Hongwei, Chi Feng, Khalaf Naila K. and Jong Ambrose, Chemoinfectomics in Drug Design and Development, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020003
DOI https://dx.doi.org/10.2174/2211352511311020003 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimers Disease
Current Alzheimer Research Editorial (Thematic Issue: MiRNAcles in the Brain: What to Wish and What to Fear)
CNS & Neurological Disorders - Drug Targets Towards A Superior Streptokinase for Fibrinolytic Therapy of Vascular Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis
Current Pharmaceutical Design Inorganic-organic Nanomaterials for Therapeutics and Molecular Imaging Applications
Nanoscience & Nanotechnology-Asia Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review
Current Neuropharmacology Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic?
Current Medicinal Chemistry New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
Current Drug Targets Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews The Coexistence of Olfactory Groove with Optic Nerve Sheath Meningioma Presenting with Anosmia: A Case Report
Current Medical Imaging Development of Reverse Phase Ultra-fast Liquid Chromatography Using Ion-pairing Reagent for Quantitative Assessment of Ceftriaxone in Rat Serum and Cerebrospinal Fluid
Current Pharmaceutical Analysis Toll-Like Receptors and Inflammation in the CNS
Current Drug Targets - Inflammation & Allergy Uropathogenic Escherichia coli Mediated Urinary Tract Infection
Current Drug Targets Naturally Occurring and Synthetic Imidazoles: Their Chemistry and Their Biological Activities
Current Medicinal Chemistry HIV-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis
Current Pharmaceutical Biotechnology Antiretroviral and Antituberculosis Therapy in HIV-TB Co-Infected Children
Current Pediatric Reviews Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism
Current Pharmaceutical Design High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders
Current HIV Research Antiidiotype-Derived Killer Peptides As New Potential Tools to Combat HIV-1 and AIDS-Related Opportunistic Pathogens
Anti-Infective Agents in Medicinal Chemistry Screening of Natural Lead Molecules Against Putative Molecular Targets of Drug-resistant Cryptococcus spp: An Insight from Computer-aided Molecular Design
Current Topics in Medicinal Chemistry